mortality risk and end-stage renal disease (ESRD) have been studied in a meta-analysis [2] .
Introduction
Chronic kidney disease (CKD) staging, based on estimated glomerular filtration rate (eGFR) categories, was recently revised to include risk strata for urinary albumin-to-creatinine ratio (ACR) [1] . The associations between eGFR and ACR categories by age for all-cause
Results

Baseline Characteristics
Baseline characteristics and deaths are shown for the age strata in Table 1 for 26,887 with 3,989 deaths (15%). Of the entire cohort, 40% were AfricanAmerican and 25% were <58 years of age at enrollment. Male preponderance, systolic blood pressure, prevalent cardiovascular disease, albuminuria >30 mg/dL, and eGFR <60 mL/min/1.73 m 2 increased across the age strata. The number of blacks, total cholesterol, and current smoking status decreased across the age strata. As expected, all-cause mortality rates increased with age. Table 2 a shows all-cause mortality across age, eGFR, and ACR strata, with the number of deaths expressed as a percentage. Higher mortality rates were associated with lower eGFR categories, and especially for subjects with (14) 20 (47) 20 (21) 61 (63) 139 (44) 171 (70) Values are n or n (%). a The mortality rates were calculated as the percentage of deaths in each cell. a Incidence rate; deaths per 1,000 patient year. The incidence rate ratios in Table 2c were calculated for each gender and age >70 years; the reference group had eGFR >80 and <100 mL/min/1.73 m 2 and ACR <30 mg/g creatinine. Color coding for absolute risk of all-cause mortality: green, <6.0; yellow, >6.0 and <8.0; orange, >8.0 and <12.0; red, >12.0. Color version available online.
Risk Summaries for All-Cause Mortality: "Heat Maps"
The absolute mortality rates (Table 3b) for each cell were obtained by multiply the incidence rate ratios by the mortality rate for the eGFR 80-100, ACR <30 mg/g group in column 1 (indicated by*).
ACR, urinary albumin-to-creatinine ratio; eGFR, creatinine-based estimated glomerular filtration rate.
Color version available online
Demographics, CKD and All-Cause Mortality 295 ACR >30 mg/g. As expected, higher mortality rates were observed with increasing age categories for all strata.
Relative risks for mortality across the age strata, relative to a common reference at eGFR between 80 and 100 mL/min/1.73 m 2 and ACR <30 mg/g are shown in Table 2 b. Arbitrary color coding corresponds to increasing relative risk (see legend). The relative risk for all-cause mortality was attenuated for older subjects, and the relative risk is similar for eGFR strata >45 mL/min/1.73 m 2 and ACR <30 mg/g. Table 2 c shows the absolute risk for mortality across the age strata. Incidence rate ratios were calculated relative to a common reference at eGFR between 80 and 100 mL/min/1.73 m 2 , ACR <30 mg/g, and age <60 years. Arbitrary color coding corresponds to increasing absolute risk (see legend). The absolute risk for allcause mortality was increased for older REGARDS participants (age >70 years), and the absolute risk was similar for eGFR strata >45 mL/min/1.73 m 2 , and ACR <30 mg/g was similar for subjects <70 years. The absolute risk for mortality increased with age and ACR >30 mg/g. Table 3 shows the relative risk for mortality for race and gender strata, among subjects >70 years of age. Arbitrary color coding corresponds to increasing absolute risk (see legend). The relative risk for all-cause mortality was attenuated for black subjects compared to white subjects >70 years of age ( Table 3 a), and for female subjects compared to male subjects >70 years of age and ACR <30 mg/g ( Table 3 b).
Discussion
We describe mortality risk for REGARDS participants based on demographic strata, eGFR, and ACR categories using incidence rates and incidence rate ratios for allcause mortality. Risk summaries ("heat maps") show notable differences across demographic strata.
The relative risks for all-cause mortality were attenuated for the older age strata ( Table 2 b) , while the absolute risk for mortality increased with age ( Table 2 c). For example, the relative risks for mortality among participants with eGFR >60 and <80 mL/min/1.73 m 2 , and a Incidence rate ratio; relative to the reference group for each age strata.
Color coding for absolute risk of all-cause mortality: light green, <1.0; green, >1 and <1.5; yellow, >1.5 and <2.5; orange, >2.5 and <4.0; red, >4.0. Color version available online.
ACR, urinary albumin-to-creatinine ratio; eGFR, creatinine-based estimated glomerular filtration rate [9] . Table 2 c) . Similar patterns were seen across the same eGFR and age strata for ACR >30 mg/g. Previous commentaries have emphasized the attenuation of the relative risk for all-cause mortality among older subjects [4] . The present analysis confirms this finding, but also extends the analysis to show the expected increase in absolute risk for all-cause mortality with increasing age. Similar observations about the increase in mortality rates with age and ACR levels are described by Hallan et al. [2] .
Furthermore, the gender and race differences in relative risk for all-cause mortality shown in Table 3 a and b suggest that these strata as well as age should also be considered when assessing the relative risk for all-cause mortality among a specified cohort of patients. This conclusion is consistent with longitudinal descriptions of the risk for all-cause mortality described for elderly Swedish women [11] .
The KDIGO Controversies Conference Report [10] included "heat maps" for separate outcome events, including all-cause mortality, cardiovascular mortality, ESRD, acute kidney injury, and progressive CKD. The relative risk summary table for all-cause mortality [10] is similar to the absolute risk summary. It used similar reference groups (ACR <10 and <30 mg/g, eGFR 90-105 and 80-100 mL/min/1.73 m 2 ), with mortality incidence rates of 7.0 and 5.13 deaths per 1,000-person years, respectively. Absolute risk in Table 2 c was generated by multiplying incidence rate ratios by the absolute risk for the reference group, as previously described [10] . As expected, the risk for all-cause mortality increased with aging.
With the goal of confirming a single all-encompassing risk summary scheme [1] , Hallan et al. [2] examined risk summaries for age strata, eGFR, and ACR categories with a meta-analysis of 33 general population cohorts, including over 2 million participants with 112,325 deaths, including 27,306 REGARDS participants. Risk for all-cause mortality differ across age strata, both for relative risk and absolute risk [2] , supporting the use of different risk summaries for different outcome events, demographic strata, and eGFR and ACR strata.
We conclude that the differences between relative and absolute risks for all-cause mortality have not received sufficient emphasis. Furthermore, there may be differences in the absolute and relative risks across age-strata that require further analyses for gender and race strata. The REGARDS cohort is not large enough to fully define these strata, and was recruited with the goal of including subjects >45 years of age, and an equal number of men, women, and white and black participants. Additional meta-analysis of combined general population cohorts seems worthwhile.
It has been proposed that the cutpoints for CKD stages be adjusted for age strata, described as an age-calibrated definition of CKD [3] [4] [5] , to account for the attenuation of relative risk for all-cause mortality observed with older subjects. This approach has not been widely accepted [12] , and represents a post-hoc modification of risk assessment that does not address the underlying weaknesses inherent when such analyses include eGFR as an effect variable [8] . The current proposal to use separate heat maps for age, race, and gender strata rather than a single all-encompassing risk summary may accomplish the basic goal of providing risk assessments in CKD that reflect the demographic and kidney-specific factors for an individual patient.
